Neurotransmitters such as dopamine, serotonin, and gamma-aminobutyric acid (GABA) play pivotal roles in addiction. Dopamine, often linked to the brain's reward system, is excessively released during substance use, reinforcing the behavior and creating a cycle of dependency. Serotonin dysregulation can lead to mood disturbances, increasing susceptibility to addiction. GABA, a neurotransmitter responsible for calming the brain, becomes imbalanced, leading to heightened anxiety and withdrawal symptoms. These disruptions alter neural pathways, making it challenging to break free from addiction. Recovery often focuses on restoring neurotransmitter balance through pharmacological interventions and behavioral therapies. Understanding the role of neurotransmitters sheds light on addiction's complexity, emphasizing the importance of tailored treatment strategies that address these biochemical changes for sustainable recovery.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States